Summary of Loading Off Q2 > Annual Report Bottom - As At
Summary of Loading Off Q2 > Annual Report Bottom - As At Close July 16.
Bought at .0006:
May 11: 1M [rounded up]
June 1: 1M [rounded up]
June 20: 1M [rounded up]
June 22: 13M [rounded down]
June 25: 6M [rounded up]
June 26: 82M [rounded down]
June 28: 5M [rounded up]
June 29: 3M [rounded up]
July 9: 2M [rounded down]
Total: 114M
Bought at .0005:
January 19: 3M
January 23: 3M
May 8: 2M
May 9: 12M [rounded down]
May 10: 34M [rounded up]
May 11: 21M [rounded down]
May 14: 3M [rounded up]
May 18: 5M
May 21: 1M [rounded down]
May 23: 1M [rounded up]
May 31: 20M [rounded up]
June 1: 61M
June 5: 6M [rounded up]
June 19: 26M [rounded down]
June 20: 95M [rounded up]
June 21 22M [rounded up]
June 22: 9M [rounded down]
June 26: 13M
June 27: 13M [rounded up]
June 28: 32M [rounded down]
June 29 6M [rounded up]
July 2: 29M [rounded up]
July 5: 17M [rounded up]
July 6: 1M [rounded down]
July 9: 14M
July 11: 1M [rounded up]
July 12: 8M [rounded down]
July 13: 9M [rounded up]
July 16: 7M [rounded down]
Total: 474M
Bought at .0004:
August 23: 9.5M
September 1: 1.5M
September 6: 4M
September 7: 1M
September 11: 5M
September 15: 63M
September 21: 1M
September 26: 62M
September 27: 65M
September 28: 36M
September 29: 7M
October 2: 13M
October 3: 1M
October 5: 5M
October 6: 11M
October 9: 4M
October 11: 14M
October 12: 1M
October 16: 9M
October 17: 6M
October 18: 2M
October 19: 1M
October 23: 2M
October 24: 3M
October 25: 7M
October 26: 16M
October 31: 3M
November 2: 1M
November 3: 3M
November 6: 4M
November 7: 1M
November 9: 1M
November 10: 4M
November 14: 3M
November 16: 1M
November 17: 5M [discounting double print of a 2M buy]
November 20: 10M
November 21: 2M
November 22: 2M
November 24: 2M
November 27: 4M
November 28: 1M
November 30: 3M
December 5: 2M
December 12: 1M
December 14: 1M
December 28: 9M
December 29: 4M
January 3: 7M
January 5: 1M [rounded down from 1.4M]
January 8: 1M
January 11: 51M
January 19: 20M
January 24: 3M
January 29: 1M [rounded up from 684K with 500K from January 26]
January 30: 2M [rounded up from 1.7M]
February 2: 6M
February 5: 2M
February 6: 4M
February 8: 5M
February 9: 2M
February 12: 2M
February 13: 2M
February 14: 3M
February 15: 8M
February 16: 1M
March 2: 4M [rounded up]
March 5: 4M [rounded down]
March 6: 1M
March 7: 1M [rounded up]
March 8: 2M [rounded down]
March 9: 3M [rounded up]
March 12: 11M
March 13: 5M
March 22: 12M
March 23: 6M [rounded down]
March 28: 2M
Aoril 17: 1M
April 25: 1M [rounded up]
May 4: 13M [rounded up]
May 7: 57M
May 8: 13M [rounded down]
May 9: 16M [rounded down]
May 10: 6M
May 14: 10M [rounded down]
May 15: 15M [rounded up]
May 16: 2M
May 17: 18M
May 18: 5M
May 21: 8M [rounded down]
May 23: 33M [rounded down]
May 24: 7M [rounded down]
May 29: 2M
May 30: 32M [rounded down]
May 31: 22M [ rounded up]
June 1: 32M [rounded down]
June 5: 5M [rounded down]
June 6: 14M [rounded down]
June 7: 5M [rounded up]
June 8: 3M [rounded up]
June 12: 14M [rounded up]
June 13: 2M [rounded down]
June 14: 41M [rounded up]
June 15: 33M [rounded up]
June 18: 18M [rounded down]
June 19: 3M [rounded down]
June 20: 1M [rounded down]
June 28: 1M
July 9: 1M [rounded down]
Total: 1018M
Bought at .0003:
September 15: 1M
October 2: 3M
October 6: 3M
October 9: 7M
October 17: 1M [rounded up from 850K]
November 22: 3M
November 30: 1M
December 1: 11M
December 5: 30M
December 6: 4M [rounded down from 4.4M]
December 7: 8M
December 8: 13M
December 12: 2M
December 14: 96M
December 15: 13M
December 18: 5M
December 19: 3M
December 21: 2M
December 22: 2M
December 27: 2M
December 28: 3M
December 29: 8M
January 2: 1M [rounded down from 1.5M]
January 3: 13M
January 4: 1M [rounded up from 800K]
January 10: 1M
January 18: 13M [rounded down from 13.4M]
February 6: 1M
February 12: 3M
February 14: 1M [rounded up]
February 16: 1M
February 21: 2M [rounded down]
March 1: 1M [rounded up]
March 14: 4M
March 20: 12M [rounded down]
March 22: 5M
March 23: 7M
March 28: 4M [rounded up]
April 2: 11M [rounded up]
April 3: 10M [rounded down]
April 5: 8M [rounded down]
April 9: 3M [rounded down]
April 10: 1M [rounded down]
April 11: 5M [rounded up]
April 12: 2M
April 13: 2M [rounded up]
April 17: 13M
April 18: 3M [rounded up]
May 1: 4M
May 24: 1M [rounded up]
June 12: 4M
June 14: 2M [rounded down]
Total 362M
Bought at .0002:
April 17: 5M [rounded up]
Total: 5M [out of 138M bid]
American EcoFuels Inc (AEFI) Stock Research Links
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...
Continue Reading
Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...
Continue Reading
Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...
Continue Reading
Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...
Continue Reading
An Unexpected Turn in the Drug Discovery Arena It's not every day that you see a historic French pharma powerhouse and a cutting-edge Chinese tech firm join forces. On one side, we've got Laboratoires Pierre Fabre, steeped in the history and nitty-gritty of clinical drug development. On the other, we’ve got XtalPi Holdings Limited (2228.HK), bringing their high-tech AI...
Continue Reading
Revving Up With Incentives: A Strategic Move by Cars.com Ever seen a stock maneuver that feels more like a chess play than a plain deal? On November 5, 2026, Cars.com (NYSE: CARS) fired up quite a strategic engine. They handed out a heap of restricted stock units—373,345 to be precise—to Mausam Bhatt, freshly minted as their Chief Product Officer. This isn't just your...
Continue Reading
CMC Strategies: The Unsung Hero in Biotech Development Ah, the world of biotech, where one day you're a hero in the lab, and the next you're scrambling to make sense of chemistry, manufacturing, and controls (CMC). It's high time folks started realizing that CMC isn't just procedural drudgery—it's the backbone of making a promising drug go global. That's what the...
Continue Reading
The Need for Unity in a Warming World Some folks out there might be scratching their heads, wondering what sparks are flying between China, Europe, and Africa this time. Well, during the 2026 China-Europe-Africa Green Energy Development Forum held in sunny Zhejiang, the theme was loud and clear: We've got to deepen green partnerships to build a zero-carbon future. They're...
Continue Reading
KT&G Lights Up Kazakhstan In a bold move, KT&G is laying down the gauntlet in Kazakhstan's tobacco market, introducing its cutting-edge heated tobacco gizmo and a handful of sleek FAIIM sticks. Launching this October, these aren't just any devices—they're the FLEX locals have been waiting for, rebranded from South Korea's lil AIBLE and AIIM but made to fit right in with...
Continue Reading
MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...
Continue Reading
Top 5 Most Recently Viewed Articles
Penns Woods Banco Hits a 52-Week High Stock Price Penns Woods Banco Inc. (PWOD) has recently made headlines in the financial world by reaching a notable milestone with its stock price hitting a 52-week high of $24.25. This achievement is more than just a number; it represents a significant accomplishment for the regional bank holding company, which has witnessed a...
Continue Reading
Wolfspeed’s Short Interest Is Climbing Wolfspeed (WOLF) has seen a clear pickup in short interest, rising 12.72% since the last read. The latest tally shows 24.14 million shares sold short, equal to 26.5% of the shares available to trade. One more useful measure: at current trading volumes, it would take about 5.76 days on average for short sellers to buy back those...
Continue Reading
Google Collaborates with SandboxAQ for Advanced AI Models In an exciting development in the realm of artificial intelligence, Google Cloud has partnered with SandboxAQ, a distinguished quantum startup. This collaboration aims to enhance Google's cloud services by integrating SandboxAQ's large quantitative models (LQMs), designed to manage extensive numerical data, execute...
Continue Reading
Gold Grows Despite the Higher-Than-Expected US CPI Data Gold experienced a notable upswing, reversing its previous bearish trend during a trading session influenced by rising US inflation data. The XAU/USD pair gained 0.87% even as the US dollar saw strength from the latest Consumer Price Index (CPI) report. Market dynamics such as geopolitical uncertainty and...
Continue Reading
NRx Pharmaceuticals Shares Insights at Investment Conference Wilmington, Delaware — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a dedicated clinical-stage biopharmaceutical company focused on groundbreaking treatments, is set to participate in an engaging fireside chat at the highly anticipated H.C. Wainwright's 27th Annual Global Investment Conference. Event Details and...
Continue Reading